Spots Global Cancer Trial Database for metastatic angiosarcoma

Every month we try and update this database with for metastatic angiosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma	NCT04668300	Metastatic Angi... Metastatic Dedi... Metastatic Oste... Recurrent Angio... Recurrent Dedif... Recurrent Osteo... Refractory Dedi... Refractory Oste...	Durvalumab Oleclumab	12 Years -	M.D. Anderson Cancer Center
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery	NCT03009201	Advanced Soft T... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Angi... Metastatic Epit... Metastatic Fibr... Metastatic Lipo... Metastatic Mali... Metastatic Myxo... Metastatic Soft... Metastatic Syno... Metastatic Undi... Myxofibrosarcom... Pleomorphic Rha... Stage III Soft ... Stage IV Soft T... Undifferentiate... Unresectable Le... Unresectable Li... Unresectable Ma... Unresectable So... Unresectable Sy... Unresectable Un...	Doxorubicin Hyd... Laboratory Biom... Pharmacological... Ribociclib	12 Years -	OHSU Knight Cancer Institute
Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study	NCT05026736	Locally Advance... Metastatic Angi... Recurrent Angio...	Quality-of-Life... Sintilimab	18 Years -	M.D. Anderson Cancer Center
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery	NCT03009201	Advanced Soft T... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Angi... Metastatic Epit... Metastatic Fibr... Metastatic Lipo... Metastatic Mali... Metastatic Myxo... Metastatic Soft... Metastatic Syno... Metastatic Undi... Myxofibrosarcom... Pleomorphic Rha... Stage III Soft ... Stage IV Soft T... Undifferentiate... Unresectable Le... Unresectable Li... Unresectable Ma... Unresectable So... Unresectable Sy... Unresectable Un...	Doxorubicin Hyd... Laboratory Biom... Pharmacological... Ribociclib	12 Years -	OHSU Knight Cancer Institute
Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study	NCT05026736	Locally Advance... Metastatic Angi... Recurrent Angio...	Quality-of-Life... Sintilimab	18 Years -	M.D. Anderson Cancer Center
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery	NCT03009201	Advanced Soft T... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Angi... Metastatic Epit... Metastatic Fibr... Metastatic Lipo... Metastatic Mali... Metastatic Myxo... Metastatic Soft... Metastatic Syno... Metastatic Undi... Myxofibrosarcom... Pleomorphic Rha... Stage III Soft ... Stage IV Soft T... Undifferentiate... Unresectable Le... Unresectable Li... Unresectable Ma... Unresectable So... Unresectable Sy... Unresectable Un...	Doxorubicin Hyd... Laboratory Biom... Pharmacological... Ribociclib	12 Years -	OHSU Knight Cancer Institute

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: